Literature DB >> 15133510

Mutations in SEC63 cause autosomal dominant polycystic liver disease.

Sonia Davila1, Laszlo Furu, Ali G Gharavi, Xin Tian, Tamehito Onoe, Qi Qian, Airong Li, Yiqiang Cai, Patrick S Kamath, Bernard F King, Pablo J Azurmendi, Pia Tahvanainen, Helena Kääriäinen, Krister Höckerstedt, Olivier Devuyst, Yves Pirson, Rodolfo S Martin, Richard P Lifton, Esa Tahvanainen, Vicente E Torres, Stefan Somlo.   

Abstract

Mutations in PRKCSH, encoding the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum (ER), cause autosomal dominant polycystic liver disease. We found that mutations in SEC63, encoding a component of the protein translocation machinery in the ER, also cause this disease. These findings are suggestive of a role for cotranslational protein-processing pathways in maintaining epithelial luminal structure and implicate noncilial ER proteins in human polycystic disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133510     DOI: 10.1038/ng1357

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  101 in total

Review 1.  Polycystic liver diseases: congenital disorders of cholangiocyte signaling.

Authors:  Mario Strazzabosco; Stefan Somlo
Journal:  Gastroenterology       Date:  2011-04-22       Impact factor: 22.682

2.  BiP modulates the affinity of its co-chaperone ERj1 for ribosomes.

Authors:  Julia Benedix; Patrick Lajoie; Himjyot Jaiswal; Carsten Burgard; Markus Greiner; Richard Zimmermann; Sabine Rospert; Erik L Snapp; Johanna Dudek
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

3.  Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation.

Authors:  Ramón Peces; Joost P H Drenth; Rene H M Te Morsche; Pedro González; Carlos Peces
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

4.  A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection.

Authors:  Taro Akihisa; Ayami Ino; Hiroto Egawa; Yoshihito Kotera; Shunichi Ariizumi; Akiko Oomori; Shingo Yamashita; Yusuke Yamamoto; Ken Tsuchiya; Masakazu Yamamoto; Kosaku Nitta; Toshio Mochizuki
Journal:  CEN Case Rep       Date:  2018-06-28

5.  Polycystic liver disease: The interplay of genes causative for hepatic and renal cystogenesis.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

6.  HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.

Authors:  Sergio A Gradilone; Stefan Habringer; Tatyana V Masyuk; Brynn N Howard; Anatoliy I Masyuk; Nicholas F Larusso
Journal:  Am J Pathol       Date:  2014-01-13       Impact factor: 4.307

7.  Polycystin-1, the product of the polycystic kidney disease gene PKD1, is post-translationally modified by palmitoylation.

Authors:  Kasturi Roy; Ethan P Marin
Journal:  Mol Biol Rep       Date:  2018-08-02       Impact factor: 2.316

8.  Loss of oriented cell division does not initiate cyst formation.

Authors:  Saori Nishio; Xin Tian; Anna Rachel Gallagher; Zhiheng Yu; Vishal Patel; Peter Igarashi; Stefan Somlo
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

9.  Glucosidase II beta subunit modulates N-glycan trimming in fission yeasts and mammals.

Authors:  Ivan D Stigliano; Julio J Caramelo; Carlos A Labriola; Armando J Parodi; Cecilia D'Alessio
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

10.  Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.

Authors:  Paolo Onori; Romina Mancinelli; Antonio Franchitto; Guido Carpino; Anastasia Renzi; Stefania Brozzetti; Julie Venter; Heather Francis; Shannon Glaser; Douglas M Jefferson; Gianfranco Alpini; Eugenio Gaudio
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.